IDEAYA Biosciences, Inc.
IDYA
$18.58
-$0.38-2.00%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | 145.28% | 4.80% | |||
Gross Profit | -133.03% | -4.80% | |||
SG&A Expenses | 12.46% | -6.28% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 125.94% | 3.03% | |||
Operating Income | -115.48% | -3.03% | |||
Income Before Tax | -151.47% | 1.80% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -151.47% | 1.80% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -151.47% | 1.80% | |||
EBIT | -115.48% | -3.03% | |||
EBITDA | -116.49% | -3.13% | |||
EPS Basic | -148.13% | 11.17% | |||
Normalized Basic EPS | -192.36% | 11.18% | |||
EPS Diluted | -148.13% | 11.17% | |||
Normalized Diluted EPS | -192.36% | 11.18% | |||
Average Basic Shares Outstanding | 1.34% | 10.55% | |||
Average Diluted Shares Outstanding | 1.34% | 10.55% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |